These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8557030)

  • 1. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
    Berx G; Cleton-Jansen AM; Nollet F; de Leeuw WJ; van de Vijver M; Cornelisse C; van Roy F
    EMBO J; 1995 Dec; 14(24):6107-15. PubMed ID: 8557030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
    Berx G; Cleton-Jansen AM; Strumane K; de Leeuw WJ; Nollet F; van Roy F; Cornelisse C
    Oncogene; 1996 Nov; 13(9):1919-25. PubMed ID: 8934538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
    Cleton-Jansen AM
    Breast Cancer Res; 2002; 4(1):5-8. PubMed ID: 11879552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
    Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
    Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.
    Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR
    Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
    Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
    Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast.
    Kashiwaba M; Tamura G; Suzuki Y; Maesawa C; Ogasawara S; Sakata K; Satodate R
    Jpn J Cancer Res; 1995 Nov; 86(11):1054-9. PubMed ID: 8567396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
    Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
    Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
    Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
    Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.
    Goyal A; Martin TA; Mansel RE; Jiang WG
    World J Surg Oncol; 2008 Jun; 6():56. PubMed ID: 18547424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast.
    Kanai Y; Oda T; Tsuda H; Ochiai A; Hirohashi S
    Jpn J Cancer Res; 1994 Oct; 85(10):1035-9. PubMed ID: 7961105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.
    Rakha EA; Armour JA; Pinder SE; Paish CE; Ellis IO
    Int J Cancer; 2005 May; 114(5):720-9. PubMed ID: 15609312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
    Chappell SA; Walsh T; Walker RA; Shaw JA
    Br J Cancer; 1997; 75(9):1324-9. PubMed ID: 9155053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
    Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
    Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer.
    Chalmers IJ; Aubele M; Hartmann E; Braungart E; Werner M; Höfler H; Atkinson MJ
    Cancer Genet Cytogenet; 2001 Apr; 126(1):39-44. PubMed ID: 11343777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.